| Literature DB >> 33923797 |
Mijeong Park1, Eunyoung E Suh2, Soo-Young Yu3.
Abstract
The survival rate of pediatric cancer has increased to 80%, but long-term treatment is required. During treatment, parents experience uncertainty, which affects parents' quality of life and, even worse, their children's health; however, the variation of that uncertainty remains under-studied. Thus, it is crucial to understand parents' nursing needs in each distinct treatment phase to develop relevant educational content. This study investigated the uncertainty level and nursing needs of parents according to their children's treatment phase. This cross-sectional comparative descriptive study collected survey data from 119 people at a tertiary hospital from December 2017 to April 2018. Nursing needs were ascertained using open-ended questions, and data were analyzed using quantitative content analysis. The uncertainty levels of parents of pediatric cancer patients showed statistically significant differences across treatment phases (F = 8.209, p < 0.001). Parents' uncertainty was higher in the treatment initiation phase (87.77 ± 13.43) and when treatment was ongoing (83.33 ± 15.10) than in the post-treatment phase (75.35 ± 12.82). All three groups had nursing needs regarding infection control, diet, daily activities of living, and prognosis. Parents' uncertainty levels and nursing needs differed across treatment phases, suggesting a need for tailored education programs to provide practical support to parents of pediatric cancer patients in each phase.Entities:
Keywords: family nursing; oncology nursing; parents; pediatrics; uncertainty
Mesh:
Year: 2021 PMID: 33923797 PMCID: PMC8072720 DOI: 10.3390/ijerph18084253
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Demographic characteristics of the participants (n = 119).
| Characteristics | Categories | Median/Mean ± SD | |
|---|---|---|---|
| Relationship with the pediatric cancer patient | Father | 14 (11.8) | |
| Mother | 105 (88.2) | ||
| Age (years) | 20–29 | 4 (3.4) | 39/39.36 ± 5.42 |
| 30–39 | 56 (47.1) | ||
| 40–49 | 56 (47.1) | ||
| ≥50 | 3 (2.5) | ||
| Religious | None | 58 (48.7) | |
| Yes | 61 (51.3) | ||
| Education | ≤Middle school | 2 (1.7) | |
| High school | 23 (19.3) | ||
| ≥College/University | 94 (79.0) | ||
| Occupation | Employed | 35 (29.4) | |
| Unemployed | 84 (70.6) | ||
| Average monthly household income (KRW 10,000) | ≤199 | 21 (17.6) | |
| 200–299 | 21 (17.6) | ||
| 300–399 | 27 (22.7) | ||
| ≥400 | 50 (42.0) |
Characteristics of Children with Pediatric Cancer (n = 119).
| Characteristics | Categories | Median/Mean ± SD | |
|---|---|---|---|
| Gender | Male | 69 (58.0) | |
| Female | 50 (42.0) | ||
| Type of cancer | Acute lymphoblastic leukemia | 29 (24.4) | |
| Acute myeloid leukemia | 13 (10.9) | ||
| Acute biphenotypic leukemia | 4 (3.4) | ||
| Chronic myeloid leukemia | 1 (0.8) | ||
| Brain tumor | 16 (13.4) | ||
| Non-Hodgkin lymphoma | 14 (11.8) | ||
| Osteosarcoma | 8 (6.7) | ||
| Neuroblastoma | 8 (6.7) | ||
| Retinoblastoma | 7 (5.9) | ||
| Rhabdomyosarcoma | 6 (5.0) | ||
| Germ cell tumor | 5 (4.2) | ||
| Wilms tumor | 4 (3.4) | ||
| Ewing sarcoma | 3 (2.5) | ||
| Hepatoblastoma | 1 (0.8) | ||
| Age | 0–11 months | 7 (5.9) | 3/7.65 ± 4.98 |
| 1–5 years | 36 (30.3) | ||
| 6–10 years | 33 (27.7) | ||
| ≥11 years | 43 (36.1) | ||
| Order of birth | First | 73 (61.3) | |
| Second | 36 (30.3) | ||
| ≥Third | 10 (8.4) | ||
| Time since diagnosis | 1–11 months | 65 (54.6) | |
| ≥12 months | 54 (45.4) | ||
| Relapse | Yes | 23 (19.3) | |
| No | 96 (80.7) | ||
| Transplantation | Yes | 35 (29.4) | |
| No | 84 (70.6) |
Uncertainty score according to treatment phases in each group (n = 119).
| Subdomain | Group 1 a | Group 2 b | Group 3 c | F | |
|---|---|---|---|---|---|
| M ± SD | |||||
| Ambiguity | 37.29 ± 8.04 | 36.80 ± 8.34 | 31.60 ± 6.85 | 7.49 | 0.001 (a, b > c) |
| Lack of clarity | 24.28 ± 4.21 | 23.43 ± 4.47 | 21.75 ± 4.48 | 3.41 | 0.036 (a > c) |
| Lack of information | 11.87 ± 2.71 | 10.23 ± 2.35 | 10.48 ± 2.35 | 5.06 | 0.008 (a > b, c) |
| Unpredictability | 13.69 ± 2.70 | 12.88 ± 3.23 | 11.53 ± 2.49 | 5.94 | 0.003 (a > c) |
| Total | 87.77 ± 13.43 | 83.33 ± 15.10 | 75.35 ± 12.82 | 8.20 | <0.001 (a, b > c) |
a Group 1 = treatment initiation phase; b Group 2 = ongoing treatment phase; c Group 3 = post-treatment phase
Figure 1Uncertainty comparison according to treatment phase across four subdomains. Group 1 = treatment initiation phase; Group 2 = ongoing treatment phase; Group 3 = post-treatment phase.
Scores for each item on PPKS-FM scale across the treatment phase.
| Item | Group 1 | Group 2 | Group 3 | |
|---|---|---|---|---|
| Mean ± SD | ||||
| 1. | I am unsure if my child’s illness is getting better or worse | 3.44 ± 1.23 | 3.40 ± 1.11 | 2.78 ± 1.14 |
| 2. | It is unclear how bad my child’s pain will be | 3.72 ± 1.19 | 3.63 ± 1.03 | 2.68 ± 1.16 |
| 3. | My child’s symptoms continue to change unpredictably | 2.64 ± 1.11 | 2.73 ± 1.04 | 2.08 ± 0.97 |
| 4. | It is difficult to know if the treatments or medications my child is getting are working | 2.64 ± 0.96 | 2.65 ± 1.10 | 2.60 ± 0.98 |
| 5. | Because of the unpredictability of my child’s illness, I cannot plan for the future | 2.90 ± 1.19 | 2.88 ± 1.02 | 2.75 ± 1.10 |
| 6. | The course of my child’s illness keeps changing. He/she has good and bad days | 2.72 ± 1.05 | 2.83 ± 1.06 | 2.30 ± 0.99 |
| 7. | It’s vague to me how I will manage the care of my child after he/she leaves the hospital | 2.97 ± 1.22 | 2.33 ± 1.02 | 2.25 ± 0.98 |
| 8. | It is not clear what is going to happen to my child | 3.46 ± 1.00 | 3.28 ± 1.04 | 2.93 ± 1.10 |
| 9. | The results of my child’s tests are inconsistent | 2.69 ± 1.13 | 2.38 ± 0.90 | 2.03 ± 0.83 |
| 10. | The effectiveness of the treatment is undetermined | 2.36 ± 0.81 | 2.40 ± 1.01 | 1.80 ± 0.61 |
| 11. | It is difficult to determine how long it will be before I can care for my child by myself | 2.90 ± 0.97 | 2.48 ± 1.13 | 1.83 ± 0.81 |
| 12. | Because of the treatment, what my child can and cannot do keeps changing | 3.46 ± 1.14 | 3.88 ± 0.72 | 3.68 ± 1.02 |
| 13. | I’m certain they will not find anything else wrong with my child | 2.03 ± 1.18 | 1.98 ± 1.07 | 1.93 ± 0.92 |
| 14. | I have a lot of questions without answers | 4.21 ± 1.00 | 3.85 ± 0.83 | 3.73 ± 0.96 |
| 15. | The explanations they give about my child seem hazy to me | 2.36 ± 0.96 | 2.63 ± 0.95 | 2.23 ± 0.86 |
| 16. | The purpose of each treatment for my child is clear to me | 2.51 ± 0.68 | 2.53 ± 0.68 | 2.20 ± 0.76 |
| 17. | I do not know when to expect things will be done to my child | 3.54 ± 1.02 | 3.45 ± 0.93 | 2.63 ± 1.03 |
| 18. | I understand everything explained to me | 2.59 ± 0.72 | 2.43 ± 0.75 | 2.38 ± 0.81 |
| 19. | The doctors say things to me that have many meanings | 2.33 ± 0.81 | 2.40 ± 0.84 | 2.40 ± 1.00 |
| 20. | There are so many different types of staff; it’s unclear who is responsible for what | 2.23 ± 0.84 | 2.15 ± 0.98 | 2.18 ± 0.90 |
| 21. | I can depend on the nurses when I need them | 2.13 ± 1.06 | 1.95 ± 0.75 | 1.95 ± 0.68 |
| 22. | The doctors and nurses use everyday language so I can understand what they are saying | 2.38 ± 0.78 | 2.05 ± 0.64 | 2.08 ± 0.69 |
| 23. | I don’t know what is wrong with my child | 2.08 ± 1.13 | 1.93 ± 0.80 | 2.05 ± 1.01 |
| 24. | My child’s treatment is too complex to figure out | 2.82 ± 0.79 | 2.35 ± 0.98 | 2.10 ± 0.74 |
| 25. | They have not given my child a specific diagnosis | 2.44 ± 1.19 | 2.10 ± 1.01 | 2.08 ± 1.05 |
| 26. | My child’s diagnosis is definite and will not change | 2.49 ± 0.94 | 2.13 ± 0.94 | 2.35 ± 1.10 |
| 27. | The seriousness of my child’s illness has not been determined | 2.05 ± 1.03 | 1.73 ± 0.75 | 1.90 ± 0.81 |
| 28. | I can predict how long my child’s illness will last and feel ill | 3.69 ± 0.86 | 3.38 ± 1.17 | 3.40 ± 1.01 |
| 29. | I usually don’t know if my child is going to have a good or bad day | 3.33 ± 1.13 | 3.30 ± 1.11 | 2.78 ± 1.07 |
| 30. | I can generally predict the course of my child’s illness | 3.18 ± 1.00 | 3.03 ± 1.05 | 2.73 ± 0.91 |
| 31. | My child’s physical distress is unpredictable; I don’t know when it is going to get better or worse | 3.49 ± 0.97 | 3.18 ± 0.87 | 2.63 ± 1.03 |
a Group 1 = treatment initiation phase; b Group 2 = ongoing treatment phase; c Group 3 = post-treatment phase.
Uncertainty-related themes described by participants according to the treatment phase.
| Treatment Phase | Theme (Frequency) | Nursing Needs |
|---|---|---|
| Total | Diet for infection control (68) | Availability of the same meal as usual |
| Low-bacterial diet during the nontreatment period | ||
| Environmental management and activity restrictions to prevent infection (65) | Specific methods of environmental management | |
| The range of normal activity in daily life after discharge | ||
| Current health condition and prognosis (52) | Specific information on the patient’s current condition and prognosis | |
| Possibility of recurrence | ||
| Treatment initiation group | Prognosis and possibility of adoption to normal life (19) | Possibility to return to ordinary life as before |
| Probability of a full recovery after treatment completion | ||
| Infection prevention rules for daily activities (14) | Infection control methods at home (cleaning method, bedding management) | |
| Effective methods for environmental management and infection prevention after discharge | ||
| Ongoing treatment group | Progress of treatment and medication (34) | The severity of the disease currently (compared to the time of diagnosis) |
| Curiosity about the reasons for and side effects of a new procedure or medication | ||
| Caring for your child’s psychological state (14) | Child’s mental health and psychological care | |
| How to play with a child with illness: emotional support is needed | ||
| Adverse effects of treatment and coping strategy (9) | Ways of alleviating the side effects of treatment | |
| Post-treatment group | Prognosis after termination and re-adaptation to school or society (19) | How a child receives care after treatment and how much and how much |
| Degree of risk of recurrence | ||
| Allowable activity in daily life after treatment is over | ||
| Long-term management method and system for disease-related sequelae (15) | Description of post-treatment period from a long-term perspective | |
| Availability of detailed explanations and important points through education, lectures, and social media | ||
| Complication relief program | ||
| Emotional support after treatment ends (10) | Psychotherapy for social adaptation | |
| Relieving a child of loneliness and depression |
The numbers in parentheses e.g., “(7)” are the number of times the respondent describes.